A growing number of new cancer drugs have come on the market in recent years, yet the cost of therapies in Europe and the United States have risen. This is driving up healthcare costs, which poses a challenge not only for the Swiss social insurance system, but for patients all over the world. But are …
Support families fighting financial toxicity of cancer – here.
Lahoucine, who is stranded in Spain due to closed borders and lockdown, is suffering and needs to have an urgent operation. Rabat – Corine, a worker at the Patient Care department of the Quenet Torrent Institute in Spain, has brought to light the heartbreaking case of a Moroccan man stranded in Spain. The medical worker launched a Go …
A Moray schoolboy is cycling 100 miles this month to raise money for a breast cancer charity. Lewis Mackay, from Keith, will take on the challenge during June to help his auntie Trisha Davidson’s fundraising efforts for Breast Cancer Care. The six-year-old has already clocked up 27 miles and raised more than £2,500 alongside his …
The COVID-19 pandemic has caused unexpected financial hardships and reduced hospital capacity for cancer screenings and treatment. Cancer patients and those who’ve recently completed treatment are finding it challenging to get necessary health care during the COVID-19 pandemic, and many are experiencing financial stress trying to afford care in an increasingly difficult economic environment. Emily Ogden (Photo: …
The vast human and economic devastation of the coronavirus is evident in the numbers: more than 100,000 American lives lost, 1.9 million infected and a national unemployment rate of 13.3 percent. While the curve appears to be slowly flattening, it goes without saying that the fallout will be substantial, particularly for states and communities. When it comes …
Prices paid by NHS chemists for antidepressants and a breast cancer treatment have soared by more than 800 per cent in recent weeks Dozens of common drugs have seen huge price increases during the pandemic Thousands of Britons may have faced delays or not received vital treatments Here’s how to help people impacted by Covid-19 …
The high costs of recently licensed cancer medicines in the United States—as compared with those in Australia, France and the UK—do not translate into improved survival, quality of life, or safety for patients, according to new research from the London School of Economics and Political Science (LSE). The paper, published in the journal Social Science and …
Incidence and prevalence of prostate cancer in Sweden have increased markedly due to prostate-specific antigen (PSA) testing. Moreover, new diagnostic tests and treatment technologies are expected to further increase the overall costs. Our aims were (i) to estimate the societal costs for existing testing, diagnosis, management and treatment of prostate cancer, and (ii) to provide …